Sec. 20. A practitioner who is permitted to distribute, dispense, prescribe, conduct research with respect to, or administer ephedrine, pseudoephedrine, or a controlled substance in the course of the practitioner's professional practice or research in the United States must be certified under section 19(d)(4) of this chapter to receive information from the INSPECT program.
As added by P.L.51-2019, SEC.8.